Annual rank74
Germany · Healthcare
M1 Kliniken
M1 Med Beauty treatments are offered at more than 35 centres; its Berlin facility has six operating theatres.
FY2022–FY2025
FY2022–FY2025
FY2022–FY2025
current context only
Company profile
Treatments, medical standards and a repeatable clinic model
M1 Kliniken is a medical-aesthetics group built around the M1 Med Beauty clinic format. Doctors deliver a deliberately focused set of injectable and surgical procedures, supported by central purchasing, common protocols and the M1 Akademie training system. Outpatient centres handle recurring consultations and treatments, while the Berlin Schlossklinik concentrates plastic surgery. Following the disposal of HAEMATO Pharm, the group describes itself as a vertically integrated pure-play provider of medical aesthetics.
Treatments and access
A focused menu delivered through specialist centres
M1 Med Beauty centres concentrate on hyaluronic-acid fillers, muscle-relaxant injections and selected plastic surgery. Each treatment begins with a doctor consultation; the narrow menu is intended to build repetition and specialist routine rather than recreate a general clinic at every address.
- Explore all treatments Injectables, facial contouring and selected cosmetic surgery
- M1 Med Beauty The brand's treatment focus and specialist-centre format
- Find a specialist centre German locations and the consultation pathway
- How the group is structured Clinics, surgery, products and international presence
Surgery and medical standards
Hospital-level procedures are concentrated in Berlin
The M1 Schlossklinik in Berlin-Köpenick handles procedures including breast surgery, liposuction, eyelid lifts and body contouring. Its operating theatres, beds and specialist teams separate surgery from the lighter outpatient network. Group rules reserve injectable treatments for doctors and surgery for plastic-and-aesthetic specialists.
- Inside the Schlossklinik Surgical procedures, specialists and the Berlin facility
- Clinic management and hygiene Medical leadership, equipment and quality assurance
- Medical standards in the annual report Specialisation, audits, hygiene and product selection
- Expanding surgical capacity How surgical hubs complement nearby outpatient centres
Operating model
Training and purchasing make the format repeatable
The M1 Akademie gives physicians, specialists and dentists practical training in procedures, product use and complication management. Common protocols, internal audits, central procurement and high utilisation support consistent delivery when the brand enters another city or country. The same premises have also been used to add services such as laser treatment.
- M1 Akademie Practical techniques, products and complication management
- The specialisation model Focused treatments, central purchasing and doctor training
- M1 Laser rollout Adding diode-laser services within existing centres
- Corporate development How the Berlin format became an international network
Footprint and strategic focus
A ten-country network is now a pure-play business
M1 reported 59 clinics in ten countries in June 2026, with Germany at the centre and operations extending across Europe and Australia. The sale of HAEMATO Pharm to the PHOENIX group was completed in January 2026, removing the large pharmaceutical-trading activity and sharpening the group's stated focus on medical aesthetics.
- Current network and strategy The 59-clinic, ten-country footprint reported with Q1 2026 results
- German clinic map Addresses and patient access across the home market
- The pure-play transition Exact completion notice for the HAEMATO Pharm disposal
- M1 Select The group's medical-cosmetics brand and distribution model
Official profile sources: Unternehmensprofil - M1 Kliniken AG · M1 Kliniken AG publishes annual report for 2025 · Company: About M1 Kliniken AG - M1 Kliniken AG
Current 2026 update
What has changed in 2026?
Q1 2026 · 3 June 2026
Q1 2026latest official update
4company-specific highlights
−4%2026 stock return · context only
Beauty-segment revenue
Beauty-segment revenue increased 5.7% to EUR 27.1 million in Q1 2026.
Beauty-segment EBIT
Beauty-segment EBIT rose 37.6% to EUR 9.2 million and its margin reached 33.9%.
Group revenue
Group revenue fell 49.5% to EUR 46.8 million; M1 said the HAEMATO Pharm sale made the comparison only limitedly comparable.
Trading-segment EBIT
The Trading segment recorded an EBIT loss of EUR 4.2 million versus a EUR 2.1 million profit after the planned withdrawal from trading.
Official 2026 sources: M1 Kliniken AG publishes Q1 figures 2026 · 3 June 2026
Annual record
Ranking history
Future editions add rows; they do not rewrite the 2026 record.
| Edition | Measurement period | Rank | Revenue growth | Net-income growth | Stock return |
|---|---|---|---|---|---|
| 2026 | FY2022–FY2025 | 74 | +28% | +413% | +124% |